Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;28(10):1843-1852.
doi: 10.1002/oby.22964. Epub 2020 Sep 6.

A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD

Mary P Moore #  1   2 , Rory P Cunningham #  1   2 , Ryan J Dashek  1   3 , Justine M Mucinski  2 , R Scott Rector  1   2   4
Affiliations
Review

A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD

Mary P Moore et al. Obesity (Silver Spring). 2020 Oct.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a major health problem, and its prevalence has increased in recent years, concurrent with rising rates of obesity and other metabolic diseases. Currently, there are no FDA-approved pharmacological therapies for NAFLD, and lifestyle interventions, including weight loss and exercise, remain the cornerstones for treatment. Manipulating diet composition and eating patterns may be a sustainable approach to NAFLD treatment. Dietary strategies including Paleolithic, ketogenic, Mediterranean, high-protein, plant-based, low-carbohydrate, and intermittent fasting diets have become increasingly popular because of their purported benefits on metabolic disease. This review highlights what is currently known about these popular dietary approaches in the management of NAFLD in clinical populations with mechanistic insight from animal studies. It also identifies key knowledge gaps to better inform future preclinical and clinical studies aimed at the treatment of NAFLD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
See this image and copyright information in PMC

References

    1. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016;65: 1038–1048. - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67: 328–357. doi: 10.1002/hep.29367. - DOI - PubMed
    1. Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016;65: 1017–1025. doi: 10.1016/j.metabol.2016.01.012. - DOI - PubMed
    1. Nobili V, Day C. Childhood NAFLD: a ticking time-bomb? Gut 2009;58: 1442. doi: 10.1136/gut.2009.184465. - DOI - PubMed
    1. Bril F, Cusi K. Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinology and Metabolism Clinics 2016;45: 765–781. - PubMed

Publication types

MeSH terms